Skip to main content

Articles

Page 1 of 12

  1. Authors: Shohei Okamoto, Mizuki Sata, Megumi Rosenberg, Natsuko Nakagoshi, Kazuki Kamimura, Kohei Komamura, Erika Kobayashi, Junko Sano, Yuzuki Hirazawa, Tomonori Okamura and Hiroyasu Iso
    Citation: Health Economics Review 2024 14:20

    The original article was published in Health Economics Review 2024 14:8

  2. In response to the imperatives of universal health coverage, structural factors that may hinder the effectiveness of increased spending in sub-Saharan Africa (SSA) need attention. This study assessed the media...

    Authors: Wa Ntita Serge Kabongo and Josue Mbonigaba
    Citation: Health Economics Review 2024 14:14
  3. Traumatic injuries are rising globally, disproportionately affecting low- and middle-income countries, constituting 88% of the burden of surgically treatable conditions. While contributing to the highest burde...

    Authors: Pakwanja Twea, David Watkins, Ole Frithjof Norheim, Boston Munthali, Sven Young, Levison Chiwaula, Gerald Manthalu, Dominic Nkhoma and Peter Hangoma
    Citation: Health Economics Review 2024 14:13
  4. Multiple sclerosis (MS) is a chronic, autoimmune, and inflammatory disease. The economic burden of MS is substantial, and the high cost of Disease-modifying drugs (DMDs) prices are the main drivers of healthca...

    Authors: Nasrin Abulhasanbeigi Gallehzan, Majid Khosravi, Khosro Jamebozorgi, Nazanin Mir, Habib Jalilian, Samira Soleimanpour, Saeed Hoseini, Aziz Rezapour and Abbas Eshraghi
    Citation: Health Economics Review 2024 14:12
  5. Adverse drug events (ADEs) are not only a safety and quality of care issue for patients, but also an economic issue with significant costs. Because they often occur during hospital stays, it is necessary to ac...

    Authors: Maxime Durand, Christel Castelli, Clarisse Roux-Marson, Jean-Marie Kinowski and Géraldine Leguelinel-Blache
    Citation: Health Economics Review 2024 14:11
  6. Studies that examine the broad allocation of resources, regardless of who bears the costs, should ideally estimate costs from a societal perspective. We have successfully integrated survival rates, employment ...

    Authors: Fuhmei Wang, Jing-Shiang Hwang, Wen-Yen Huang, Yu-Tzu Chang and Jung-Der Wang
    Citation: Health Economics Review 2024 14:10
  7. Federally qualified health centers (FQHCs) are integral to the U.S. healthcare safety net and uniquely situated in disadvantaged neighborhoods. The 2009 American Recovery and Reinvestment Act (ARRA) invested $...

    Authors: Elizabeth L. Tung, Nour Asfour, Joshua D. Bolton, Elbert S. Huang, Calvin Zhang and Luc Anselin
    Citation: Health Economics Review 2024 14:9
  8. Universal health coverage means that all people can access essential health services without incurring financial hardship. Even in countries with good service coverage and financial protection, the progress to...

    Authors: Shohei Okamoto, Mizuki Sata, Megumi Rosenberg, Natsuko Nakagoshi, Kazuki Kamimura, Kohei Komamura, Erika Kobayashi, Junko Sano, Yuzuki Hirazawa, Tomonori Okamura and Hiroyasu Iso
    Citation: Health Economics Review 2024 14:8

    The Correction to this article has been published in Health Economics Review 2024 14:20

  9. Clinical trials have demonstrated the efficacy of edaravone dexborneol in the treatment of acute ischemic stroke. This study aims to determine the cost-effectiveness of edaravone dexborneol compared with human...

    Authors: Pingyu Chen, Mengjie Luo, Yanqiu Chen, Yanlei Zhang, Chao Wang and Hongchao Li
    Citation: Health Economics Review 2024 14:7
  10. Health economics is a thriving sub-discipline of economics. Applied health economics research is considered essential in the health care sector and is used extensively by public policy makers. For scholars, it...

    Authors: Clara C. Zwack, Milad Haghani and Esther W. de Bekker-Grob
    Citation: Health Economics Review 2024 14:6
  11. While COVID-19 hospitalization costs are essential for policymakers to make informed health care resource decisions, little is known about these costs in western Europe. The aim of the current study is to anal...

    Authors: Leslie R. Zwerwer, Jan Kloka, Simon van der Pol, Maarten J. Postma, Kai Zacharowski, Antoinette D. I. van Asselt and Benjamin Friedrichson
    Citation: Health Economics Review 2024 14:4
  12. This study compared the clinical efficacy and cost-effectiveness of parenteral iron, using intravenous iron sucrose (IVIS) therapy against the standard regimen of oral iron (OI) therapy for managing iron-defic...

    Authors: Somen Saha, Devang Raval, Komal Shah and Deepak Saxena
    Citation: Health Economics Review 2024 14:3
  13. Expanding health insurance is a critical step towards universal health coverage due to its positive effect on reducing unmet health care needs and enhancing equitable access to health care. Despite previous st...

    Authors: Jingxian Wu, Yongmei Yang, Ting Sun and Sucen He
    Citation: Health Economics Review 2024 14:2

    The Correction to this article has been published in Health Economics Review 2024 14:19

  14. Upcoding in Medicare has been a topic of interest to economists and policy makers for nearly 40 years. While upcoding is generally understood as “billing for services at higher level of complexity than the ser...

    Authors: Keith A. Joiner, Jianjing Lin and Juan Pantano
    Citation: Health Economics Review 2024 14:1
  15. The purpose of this study was to analyze the current status, the research hot spots and frontiers of cognitive impairment (CI) on old adults from 2012 to 2022 based on Web of Science (WoS) and China National K...

    Authors: Shuyi Yan, Mingli Pang, Jieru Wang, Rui Chen, Hui Liu, Xixing Xu, Bingsong Li, Qinling Li and Fanlei Kong
    Citation: Health Economics Review 2023 13:56

    The Correction to this article has been published in Health Economics Review 2024 14:15

  16. Historically, the NHS did not routinely collect cost data, unlike many countries with private insurance markets. In 1998, for the first time the government mandated NHS trusts to submit estimates of their cost...

    Authors: Ben Amies-Cull, Ramon Luengo-Fernandez, Peter Scarborough and Jane Wolstenholme
    Citation: Health Economics Review 2023 13:54
  17. Palbociclib and Ribociclib are cyclin-dependent kinase 4/6 oral molecular inhibitors that have the potential to improve overall survival (OS), progression-free survival (PFS), and quality of life in patients w...

    Authors: Ali Darvishi, Rajabali Daroudi and Ali Akbar Fazaeli
    Citation: Health Economics Review 2023 13:53
  18. Improving access to facility-based delivery care has the potential to reduce maternal and newborn deaths across settings. Yet, the access to a health facility for childbirth remains low especially in low-incom...

    Authors: Peter Binyaruka, Anna Foss, Abdullah Alibrahim, Nicholaus Mziray, Rachel Cassidy and Josephine Borghi
    Citation: Health Economics Review 2023 13:52
  19. Forecasting patient arrivals to hospital emergency departments is critical to dealing with surges and to efficient planning, management and functioning of hospital emerency departments.

    Authors: Juan C. Reboredo, Jose Ramon Barba-Queiruga, Javier Ojea-Ferreiro and Francisco Reyes-Santias
    Citation: Health Economics Review 2023 13:51
  20. The escalating prevalence of type 2 diabetes (T2DM) poses an unparalleled economic catastrophe to developing countries. Cardiovascular diseases remain the primary source of costs among individuals with T2DM, i...

    Authors: Ana Claudia Cavalcante Nogueira, Joaquim Barreto, Filipe A. Moura, Beatriz Luchiari, Abrão Abuhab, Isabella Bonilha, Wilson Nadruz, J. Michael Gaziano, Thomas Gaziano, Luiz Sergio F. de Carvalho and Andrei C. Sposito
    Citation: Health Economics Review 2023 13:50
  21. Previous studies have argued that the relationship between health expenditures and health outcomes is more significant among the poor than the non-poor. However, public spending alone does not improve health s...

    Authors: Marilys Victoire Razakamanana, Voahirana Tantely Andrianatoandro and Tiarinisaina Olivier Ramiandrisoa
    Citation: Health Economics Review 2023 13:47
  22. Multimorbidity and frailty represent emerging global health burdens that have garnered increased attention from researchers over the past two decades. We conducted a scientometric analysis of the scientific li...

    Authors: Penghong Deng, Chang Liu, Mingsheng Chen and Lei Si
    Citation: Health Economics Review 2023 13:46
  23. Today, heart failure is one of the leading causes of death and disability in most developed and developing countries. By 2030, more than 23.3 million people are projected to die of cardiovascular diseases each...

    Authors: Ramin Ravangard, Farideh Sadat Jalali, Marjan Hajahmadi and Abdosaleh Jafari
    Citation: Health Economics Review 2023 13:44
  24. Chronic migraine (CM) is a significant neurological condition affecting a substantial portion of the global population. The economic burden of CM includes both direct healthcare costs and indirect costs result...

    Authors: Alyaa Eltrafi, Sunil Shrestha, Ali Ahmed, Hema Mistry, Vibhu Paudyal and Saval Khanal
    Citation: Health Economics Review 2023 13:43

    The Correction to this article has been published in Health Economics Review 2023 13:49

  25. Expanding fiscal space for health can be defined as providing additional budgetary resources for health, which is highly important during biological crises. This study aimed to provide a model for financing th...

    Authors: Maryam Yaghoubi, Masoud Vahedi Idehlo, Parisa mehdizadeh and Mohammad Meskarpour Amiri
    Citation: Health Economics Review 2023 13:41
  26. Authors: Victoria L. Phillips, Ashley Xue, Marné Castillo, Dalia Santiago, Taylor Wimbly, Lisa B. Hightow-Weidman, Rob Stephenson and José A. Bauermeister
    Citation: Health Economics Review 2023 13:40

    The original article was published in Health Economics Review 2023 13:34

  27. Most people who develop chronic diseases, including cardiovascular disease (CVD), live in their homes in the community in their last year of life. Since cost-sharing is common in most countries, including thos...

    Authors: Aviad Tur-Sinai and Netta Bentur
    Citation: Health Economics Review 2023 13:37
  28. Effective integration, one of the seven strategic priorities of the Immunization Agenda 2030, can contribute to increasing vaccination coverage and efficiency. The objective of the study is to measure and comp...

    Authors: Anne Eudes Jean Baptiste, Jurjen Van der Schans, Samuel Bawa, Balcha Masresha, John Wagai, Joseph Oteri, Boubacar Dieng, Margaret Soyemi, Rufus Eshuchi, Yared G. Yehualashet, Oluwole Afolabi, Fiona Braka, André Bita and Eelko Hak
    Citation: Health Economics Review 2023 13:36
  29. Informal care provided by family members, friends, or neighbors is a major pillar in the German long-term care system. As the number of care-dependent older adults grow, ensuring their future care still relies...

    Authors: Lea de Jong, Torben Schmidt, Ann-Katrin Carstens and Kathrin Damm
    Citation: Health Economics Review 2023 13:35
  30. Cultural competency has been identified as a barrier to lesbian, gay, bisexual and transgender (LGBT) populations seeking care. Mystery shopping has been widely employed in the formal health care sector as a q...

    Authors: Victoria L. Phillips, Ashley Xue, Marné Castillo, Dalia Santiago, Taylor Wimbly, Lisa B. Hightow-Weidman, Rob Stephenson and José A. Bauermeister
    Citation: Health Economics Review 2023 13:34

    The Correction to this article has been published in Health Economics Review 2023 13:40

  31. Medical research is increasingly interdisciplinary. However, not all projects are successful and cooperation is not always sustained beyond the end of funding. This study empirically assesses the effect of con...

    Authors: Michael John, Martin Kloyer and Steffen Fleßa
    Citation: Health Economics Review 2023 13:33
  32. Stroke, a leading cause of death and long-term disability, has a considerable social and economic impact. It is imperative to investigate stroke-related costs. The main goal was to conduct a systematic literat...

    Authors: Jorgina Lucas-Noll, José L. Clua-Espuny, Mar Lleixà-Fortuño, Ester Gavaldà-Espelta, Lluïsa Queralt-Tomas, Anna Panisello-Tafalla and Misericòrdia Carles-Lavila
    Citation: Health Economics Review 2023 13:32
  33. Between 2008 and 2018, the share of robotic-assisted surgeries (RAS) for radical prostatectomies (RPEs) has increased from 3 to 46% in Germany. Firstly, we investigate if this diffusion of RAS has contributed ...

    Authors: David Kuklinski, Justus Vogel, Cornelia Henschke, Christoph Pross and Alexander Geissler
    Citation: Health Economics Review 2023 13:29

Annual Journal Metrics

  • 2022 Citation Impact
    2.4 - 2-year Impact Factor
    2.8 - 5-year Impact Factor
    1.204 - SNIP (Source Normalized Impact per Paper)
    0.836 - SJR (SCImago Journal Rank)

    2023 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    220 days submission to accept (Median)

    2023 Usage 
    566,888 downloads
    483 Altmetric mentions